Eupraxia Pharmaceuticals (EPRX.TO) Q2 2024 Earnings

8MayConfirmed
Q4 2022
Q3 2023
Q4 2023
Q2 2024
-0.59
-0.47
-0.35
-0.23

Details

Expected EPS
-0.23380894887672002
Actual EPS
-0.29126899369572
Surprise EPS
-0.06
Surprise Percent
+24.58%

Description

Eupraxia Pharmaceuticals (EPRX.TO) has reported earnings of -0.29126899369572 per share for Q2 2024.

0 Comments

Share your thoughts